Margherita Pomatto


Senior Researcher. She worked as a Post-doctoral fellow at University of Turin in Stem Cell Laboratory, Physiopathology of Atherosclerosis Laboratory, and Renal Immunopathology Laboratory. She co-founded EvoBiotech in 2019 and served as CEO until 2021. Margherita holds several patents and scientific publications.


PhD in Medical Physiopathology at the Doctoral School of Health and Life Science, University of Turin.

Master’s Degree in Medical Biotechnology, University of Turin.


Scientific activity was carried on in the field of cell and stem cell biology, oncology, regenerative medicine, inflammation and angiogenesis. She is an expert on extracellular vesicles as therapeutic agents, delivery system, and diagnostic tool. Her experience regards the molecular characterization (protein and nuclei acid content) and the study of multiple biologic activities (e.g. angiogenesis, proliferation, migration, anti-oxidant activity) of extracellular vesicles derived from stem cells, biologic fluids (e.g. serum, plasma, saliva), and plants. She is a specialist in several techniques for loading extracellular vesicles with nucleic acids and other drugs.